CVS Health Corporation

66.53-0.3200-0.48%Vol 5.44M1Y Perf 21.31%
Jun 4th, 2020 16:00 DELAYED
BID66.00 ASK66.67
Open66.29 Previous Close66.85
Pre-Market66.51 After-Market66.53
 -0.34 -0.51%  - -%
Target Price
81.56 
Analyst Rating
Moderate Buy 1.59
Potential %
22.59 
Finscreener Ranking
★★+     49.21
Insiders Trans % 3/6/12 mo.
-60/-71/-85 
Value Ranking
★★     47.85
Insiders Value % 3/6/12 mo.
-61/-98/-98 
Growth Ranking
★★+     49.24
Insiders Shares Cnt. % 3/6/12 mo.
-60/-97/-98 
Income Ranking
★+     40.32
Market Cap86.96B 
Earnings Rating
Sell
Price Range Ratio 52W %
57.98 
Earnings Date
6th May 2020

Today's Price Range

65.9566.72

52W Range

52.0477.03

5 Year PE Ratio Range

9.3028.70

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
1.46%
1 Month
8.69%
3 Months
3.37%
6 Months
-10.67%
1 Year
21.31%
3 Years
-15.56%
5 Years
-33.00%
10 Years
112.16%

TickerPriceChg.Chg.%
CVS66.53-0.3200-0.48
AAPL322.32-2.8000-0.86
GOOG1 412.18-24.2000-1.68
MSFT182.92-2.4400-1.32
XOM49.10-0.1400-0.28
WFC30.361.53005.31
JNJ146.73-1.9200-1.29
FB226.29-3.8700-1.68
GE7.740.38005.16
JPM106.442.17002.08
Financial StrengthValueIndustryS&P 500US Markets
0.60
1.00
0.56
1.42
4.30
Leverage Ratio 3.50
ProfitabilityValueIndustryS&P 500US Markets
17.80
4.90
6.60
3.80
2.75
RevenueValueIndustryS&P 500US Markets
262.27B
200.65
12.30
11.21
DividendsValueIndustryS&P 500US Markets
3.05
2.00
2.76
10.40
Payout ratio59.00
Earnings HistoryEstimateReportedSurprise %
Q01 20201.631.9117.18
Q04 20191.681.732.98
Q03 20191.771.843.95
Q02 20191.701.8911.18
Q01 20191.501.628.00
Q04 20182.072.143.38
Q03 20181.711.731.17
Q02 20181.611.694.97
Earnings Per EndEstimateRevision %Trend
6/2020 QR1.77-4.84Negative
9/2020 QR1.71-7.07Negative
12/2020 FY7.08-0.56Negative
12/2021 FY7.50-1.06Negative
Next Report Date-
Estimated EPS Next Report1.63
Estimates Count10
EPS Growth Next 5 Years %6.30
Volume Overview
Volume5.44M
Shares Outstanding1.31B
Trades Count48.79K
Dollar Volume444.70M
Avg. Volume9.68M
Avg. Weekly Volume6.02M
Avg. Monthly Volume7.24M
Avg. Quarterly Volume10.32M

CVS Health Corporation (NYSE: CVS) stock closed at 66.53 per share at the end of the most recent trading day (a -0.48% change compared to the prior day closing price) with a volume of 5.47M shares and market capitalization of 86.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 295000 people. CVS Health Corporation CEO is Larry J. Merlo.

The one-year performance of CVS Health Corporation stock is 21.31%, while year-to-date (YTD) performance is -10.45%. CVS stock has a five-year performance of -33%. Its 52-week range is between 52.04 and 77.03, which gives CVS stock a 52-week price range ratio of 57.98%

CVS Health Corporation currently has a PE ratio of 11.90, a price-to-book (PB) ratio of 1.32, a price-to-sale (PS) ratio of 0.33, a price to cashflow ratio of 6.00, a PEG ratio of 2.32, a ROA of 3.21%, a ROC of 6.02% and a ROE of 11.57%. The company’s profit margin is 2.75%, its EBITDA margin is 6.60%, and its revenue ttm is $262.26 Billion , which makes it $200.65 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.63 for the next earnings report. CVS Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $81.56, which is +22.59% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 3.05% with a dividend per share of $2.00 and a payout ratio of 59.00%.

CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 19.74, ATR14 : 1.73, CCI20 : 101.16, Chaikin Money Flow : 0.04, MACD : 1.37, Money Flow Index : 50.02, ROC : 4.59, RSI : 62.47, STOCH (14,3) : 80.07, STOCH RSI : 0.44, UO : 58.97, Williams %R : -19.93), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Buy at a value of $315 675), Eva C. Boratto (Option Excercise at a value of $965 399), Eva C. Boratto (Sold 16 260 shares of value $1 056 900 ), James D. Clark (Option Excercise at a value of $165 226), James D. Clark (Sold 9 534 shares of value $604 560 ), Jonathan C. Roberts (Option Excercise at a value of $3 754 063), Jonathan C. Roberts (Sold 57 563 shares of value $4 180 800 ), Jonathan E. Mayhew (Sold 10 556 shares of value $686 140 ), Joshua Flum (Option Excercise at a value of $1 930 689), Joshua Flum (Sold 35 406 shares of value $2 230 578 ), Karen S. Lynch (Sold 80 143 shares of value $6 010 725 ), Larry J. Merlo (Option Excercise at a value of $17 161 300), Larry J. Merlo (Sold 266 476 shares of value $19 929 740 ), Troyen A. Brennan (Option Excercise at a value of $1 287 126), Troyen A. Brennan (Sold 23 604 shares of value $1 605 072 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (62.50 %)
10 (62.50 %)
12 (63.16 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
2 (10.53 %)
Hold
4 (25.00 %)
4 (25.00 %)
5 (26.32 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.59
Moderate Buy
1.59
Moderate Buy
1.61

CVS Health Corporation

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with about 22 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Larry J. Merlo

Teplephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, USA

Number of employees: 295 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

53%47%

Bearish Bullish

56%44%

News

Stocktwits